{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:35:11Z","timestamp":1786995311004,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","aaojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ophtha.2024.03.020","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T04:17:06Z","timestamp":1711513026000},"page":"1207-1214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Trends in Plasma Exchange Use in Optic Neuritis Hospitalizations in the United States"],"prefix":"10.1016","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3643-6570","authenticated-orcid":false,"given":"Sinan","family":"Akosman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5624-1458","authenticated-orcid":false,"given":"Masumi","family":"Asahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1226-1107","authenticated-orcid":false,"given":"Bryan","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4208-2732","authenticated-orcid":false,"given":"Jason","family":"Dossantos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Tavakoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3644-7528","authenticated-orcid":false,"given":"John J.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2024.03.020_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.msard.2018.03.003","article-title":"Autoimmune and immunogenetic profile of patients with optic neuritis in a population-based cohort","volume":"21","author":"Soelberg","year":"2018","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.ophtha.2024.03.020_bib2","first-page":"59","article-title":"Infectious optic neuropathies: a clinical update","volume":"7","author":"Kahloun","year":"2015","journal-title":"Eye Brain"},{"issue":"6","key":"10.1016\/j.ophtha.2024.03.020_bib3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00055735-200212000-00006","article-title":"Acute demyelinating optic neuritis","volume":"13","author":"Foroozan","year":"2002","journal-title":"Curr Opin Ophthalmol"},{"issue":"6","key":"10.1016\/j.ophtha.2024.03.020_bib4","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1136\/bjophthalmol-2018-312046","article-title":"Distinct clinical characteristics of paraneoplastic optic neuropathy","volume":"103","author":"Xu","year":"2019","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ophtha.2024.03.020_bib5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/1120672119889008","article-title":"Inflammatory optic neuropathy in granulomatosis with polyangiitis can mimick isolated idiopathic optic neuritis","volume":"31","author":"Cl\u00e9ment","year":"2021","journal-title":"Eur J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ophtha.2024.03.020_bib6","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","article-title":"A\u00a0randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis","volume":"326","author":"Beck","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ophtha.2024.03.020_bib7","first-page":"435","article-title":"Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials","volume":"247","author":"Brusaferri","year":"2000","journal-title":"J\u00a0Neurol"},{"issue":"9349","key":"10.1016\/j.ophtha.2024.03.020_bib8","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0140-6736(02)11919-2","article-title":"Management of acute optic neuritis","volume":"360","author":"Hickman","year":"2002","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ophtha.2024.03.020_bib9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jamaophthalmol.2017.6757","article-title":"Prevalence of myelin oligodendrocyte glycoprotein and aquaporin-4\u2013IgG in patients in the Optic Neuritis Treatment Trial","volume":"136","author":"Chen","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10.1016\/j.ophtha.2024.03.020_bib10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jca.1010","article-title":"Plasma exchange for severe attacks of inflammatory demyelinating diseases of the central nervous system","volume":"16","author":"Weinshenker","year":"2001","journal-title":"J\u00a0Clin Apheresis"},{"key":"10.1016\/j.ophtha.2024.03.020_bib11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ajo.2023.02.013","article-title":"Visual outcomes following plasma exchange for optic neuritis: an international multicenter retrospective analysis of 395 optic neuritis attacks","volume":"252","author":"Chen","year":"2023","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ophtha.2024.03.020_bib12","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1001\/archophthalmol.2012.1126","article-title":"Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica","volume":"130","author":"Merle","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.ophtha.2024.03.020_bib13","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/jnnp-2017-316286","article-title":"Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders","volume":"89","author":"Bonnan","year":"2018","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.ophtha.2024.03.020_bib14","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1177\/11206721211065218","article-title":"Efficacy and safety of plasma exchange or immunoadsorption for the treatment of option neuritis in demyelinating diseases: a systematic review and meta-analysis","volume":"32","author":"Zhang","year":"2022","journal-title":"Eur J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ophtha.2024.03.020_bib15","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ana.24554","article-title":"Neuromyelitis optica: evaluation of 871 attacks and 1,153 treatment courses: therapy of NMO attacks","volume":"79","author":"Kleiter","year":"2016","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.ophtha.2024.03.020_bib16","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/1744-9987.13844","article-title":"Therapeutic plasma exchange for optic neuritis attacks in patients with neuromyelitis optica spectrum disorders","volume":"26","author":"Gonzalez","year":"2022","journal-title":"Ther Apher Dial"},{"issue":"2","key":"10.1016\/j.ophtha.2024.03.020_bib17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/1352458515581438","article-title":"Treatment of acute relapses in neuromyelitis optica: steroids alone versus steroids plus plasma exchange","volume":"22","author":"Abboud","year":"2016","journal-title":"Mult Scler J"},{"issue":"11","key":"10.1016\/j.ophtha.2024.03.020_bib18","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1002\/acn3.51203","article-title":"Effect of plasma exchange in neuromyelitis optica spectrum disorder: a systematic review and meta-analysis","volume":"7","author":"Kosiyakul","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"issue":"6","key":"10.1016\/j.ophtha.2024.03.020_bib19","doi-asserted-by":"crossref","first-page":"e504","DOI":"10.1212\/NXI.0000000000000504","article-title":"Apheresis therapies for NMOSD attacks: a retrospective study of 207 therapeutic interventions","volume":"5","author":"Kleiter","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"issue":"1","key":"10.1016\/j.ophtha.2024.03.020_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1474-4422(22)00187-9","article-title":"Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment","volume":"22","author":"Bennett","year":"2023","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.ophtha.2024.03.020_bib21","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/WNO.0000000000000700","article-title":"Acute management of optic neuritis: an evolving paradigm","volume":"38","author":"Horton","year":"2018","journal-title":"J\u00a0Neuroophthalmol"},{"issue":"9","key":"10.1016\/j.ophtha.2024.03.020_bib22","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1212\/WNL.39.9.1143","article-title":"Double-blind study of true vs. sham plasma exchange in patients treated with immunosuppression for acute attacks of multiple sclerosis","volume":"39","author":"Weiner","year":"1989","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ophtha.2024.03.020_bib23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"issue":"1","key":"10.1016\/j.ophtha.2024.03.020_bib24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1001\/archophthalmol.2007.26","article-title":"Clinical course of optic neuritis in patients with relapsing neuromyelitis optica","volume":"126","author":"Papais-Alvarenga","year":"2008","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.ophtha.2024.03.020_bib25","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/WNO.0b013e31823a9ebc","article-title":"Comparison of visual acuity and automated perimetry findings in patients with neuromyelitis optica or multiple sclerosis after single or multiple attacks of optic neuritis","volume":"32","author":"Fernandes","year":"2012","journal-title":"J\u00a0Neuroophthalmol"},{"issue":"1\u20132","key":"10.1016\/j.ophtha.2024.03.020_bib26","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jns.2010.07.011","article-title":"Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis","volume":"298","author":"Jarius","year":"2010","journal-title":"J\u00a0Neurol Sci"},{"issue":"7","key":"10.1016\/j.ophtha.2024.03.020_bib27","first-page":"1382","article-title":"Optic neuritis: a 5-year follow-up study of Chinese patients based on aquaporin-4 antibody status and ages","volume":"263","author":"Zhou","year":"2016","journal-title":"J\u00a0Neurol"},{"issue":"11","key":"10.1016\/j.ophtha.2024.03.020_bib28","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1177\/1352458519864928","article-title":"Aquaporin-4 IgG seropositivity is associated with worse visual outcomes after optic neuritis than MOG-IgG seropositivity and multiple sclerosis, independent of macular ganglion cell layer thinning","volume":"26","author":"Sotirchos","year":"2020","journal-title":"Mult Scler J"},{"issue":"10","key":"10.1016\/j.ophtha.2024.03.020_bib29","first-page":"2293","article-title":"Features of anti-aquaporin 4 antibody-seropositive Chinese patients with neuromyelitis optica spectrum optic neuritis","volume":"262","author":"Li","year":"2015","journal-title":"J\u00a0Neurol"},{"issue":"7","key":"10.1016\/j.ophtha.2024.03.020_bib30","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/archopht.126.7.994","article-title":"Treatment of acute optic neuritis: a summary of findings from the optic neuritis treatment trial","volume":"126","author":"Beck","year":"2008","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.ophtha.2024.03.020_bib31","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/WNO.0000000000000197","article-title":"Should plasma exchange be offered to patients with multiple sclerosis\u2013associated optic neuritis?","volume":"35","author":"Pula","year":"2015","journal-title":"J\u00a0Neuroophthalmol"},{"issue":"1","key":"10.1016\/j.ophtha.2024.03.020_bib32","first-page":"111","article-title":"The changing landscape of optic neuritis: a narrative review","volume":"269","author":"De Lott","year":"2022","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ophtha.2024.03.020_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102709","article-title":"Timing of plasma exchange for neuromyelitis optica spectrum disorders: a meta-analysis","volume":"48","author":"Huang","year":"2021","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.ophtha.2024.03.020_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577449","article-title":"Efficacy of plasma exchange in acute attacks of neuromyelitis optica spectrum disorders: a systematic review and meta-analysis","volume":"350","author":"Yu","year":"2021","journal-title":"J\u00a0Neuroimmunol"},{"issue":"1","key":"10.1016\/j.ophtha.2024.03.020_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/01658107.2021.1964541","article-title":"Update on optic neuritis: an international view","volume":"46","author":"Hickman","year":"2022","journal-title":"Neuroophthalmol"},{"key":"10.1016\/j.ophtha.2024.03.020_bib36","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3389\/fneur.2020.00501","article-title":"Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide","volume":"11","author":"Hor","year":"2020","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.ophtha.2024.03.020_bib37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1472-6963-11-101","article-title":"Cost-minimization analysis of the direct costs of TPE and IVIg in the treatment of Guillain-Barr\u00e9 syndrome","volume":"11","author":"Winters","year":"2011","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"10.1016\/j.ophtha.2024.03.020_bib38","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1017\/S0317167100034053","article-title":"Cost Analysis of methylprednisolone treatment of multiple sclerosis patients","volume":"25","author":"Robson","year":"1998","journal-title":"Can J Neurol Sci J Can Sci Neurol"},{"issue":"2","key":"10.1016\/j.ophtha.2024.03.020_bib39","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s40120-022-00344-w","article-title":"Efficacy of plasma exchange treatment for demyelinating optic neuritis associated with various serum antibodies: a prospective cohort study","volume":"11","author":"Fu","year":"2022","journal-title":"Neurol Ther"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016164202400201X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016164202400201X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T04:12:33Z","timestamp":1728533553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016164202400201X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S016164202400201X"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2024.03.020","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in Plasma Exchange Use in Optic Neuritis Hospitalizations in the United States","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2024.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}